Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure
- PMID: 30429724
- PMCID: PMC6232859
Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure
Abstract
There is a lack of well-established criteria for the specific measurement of fibrinolytic parameters. On behalf of the SSC, the subcommittee on Fibrinolysis started a process to develop criteria for the specific measurement of fibrinolytic variables. This report describes the criteria for the specific measurement of plasmin inhibitor activity. In summary, a plasma deficient in plasmin inhibitor should show an activity close to 0%. Plasma containing only the non-plasminogen binding form of plasmin inhibitor should show an activity nearby the activity of a plasma deficient for plasmin inhibitor. Other inhibitors of plasmin, like a 2 -macroglobulin, antithrombin in the presence of heparin, and C1-esterase inhibitor should not interfere in the assay at the level usually found in pathological conditions or at the higher normal level.
Similar articles
-
Criteria for specific measurement of plasminogen (enzymatic; procedure) in human plasma.EJIFCC. 2000 Sep 1;12(3):83-91. eCollection 2000 Sep. EJIFCC. 2000. PMID: 30532684 Free PMC article. Review.
-
Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.Thromb Haemost. 1978 Feb 28;39(1):22-31. Thromb Haemost. 1978. PMID: 77050
-
The behavior of alpha2-plasmin inhibitor in fibrinolytic states.J Clin Invest. 1977 Aug;60(2):361-9. doi: 10.1172/JCI108784. J Clin Invest. 1977. PMID: 68962 Free PMC article.
-
Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.J Lab Clin Med. 1984 Dec;104(6):962-76. J Lab Clin Med. 1984. PMID: 6239000
-
Matrix metalloproteinases and cellular fibrinolytic activity.Biochemistry (Mosc). 2002 Jan;67(1):92-8. doi: 10.1023/a:1013908332232. Biochemistry (Mosc). 2002. PMID: 11841344 Review.
Cited by
-
Plasmin inhibitor deficiency: A case report.Clin Case Rep. 2020 Jan 7;8(2):341-343. doi: 10.1002/ccr3.2624. eCollection 2020 Feb. Clin Case Rep. 2020. PMID: 32128184 Free PMC article.
References
-
- Blomback M, Abildgaard U, van den Besselaar AM, Clementson KJ, Dahlback B, Exner T, et al. Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). A Collaborative project of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH/SSC) and the Commission/Committee on Quantities and Units (in Clinical Chemistry) of the International Union of Pure and Applied Chemistry International Federation of Clinical Chemistry (IUPAC IFCC/CQU(CC)). Thromb Haemost 1994;71:375-394. - PubMed
-
- Collen D, Wiman B. Fast-acting plasmin inhibitor in human in plasma. Blood 1978; 51: 563-569 - PubMed
-
- Wiman B. Human a2-antiplasmin. Methods Enzymol 1981; 80: 395-408
-
- Welch SK, Francke U. Assignment of the human a2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids. Genomics 1982; 13: 213-214 - PubMed
LinkOut - more resources
Full Text Sources